share_log

BTIG Upgrades Globus Medical to Buy, Announces $60 Price Target

BTIG Upgrades Globus Medical to Buy, Announces $60 Price Target

BTIG将Globus Medical上调为收购,宣布目标股价为60美元
Moomoo 24/7 ·  03/18 08:06

BTIG analyst Ryan Zimmerman upgrades Globus Medical (NYSE:GMED) from Neutral to Buy and announces $60 price target.

BTIG分析师瑞安·齐默尔曼将Globus Medical(纽约证券交易所代码:GMED)从中性上调至买入,并宣布了60美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发